A purple and pink letter v on a white background.
March 14, 2025

How To Enhance Your Semaglutide/GLP-1 Patients' Results

Semaglutide and other GLP-1 receptor agonists have transformed medical weight loss. Clinics offering these treatments see strong demand, but patient success depends on more than just the medication. Without proper guidance, some individuals struggle with slow progress or weight regain after stopping treatment.


Providers must actively participate in patient education and adherence strategies for optimal outcomes. A well-structured protocol makes a significant difference in long-term success


Speak to an expert today to learn how Venus Bliss MAX™ and our advanced technologies can support your semaglutide and GLP-1 patients' success. Discover strategies to enhance treatment outcomes and optimize long-term results. Contact our team to get started!


We explore key strategies for maximizing semaglutide patient results. We discuss:


  • How To Maximize Weight Loss on Semaglutide
  • Addressing Common Side Effects
  • How To Get the Best Results From Semaglutide
  • Tracking Progress and Encouraging Accountability


Let’s get started.


How To Maximize Weight Loss on Semaglutide


Semaglutide alone isn't a long-term weight loss solution. Lasting results come when clinics provide structured plans that support sustainable progress.


The following are the best strategies for semaglutide success:


  • Nutritional Guidance: Appetite suppression can result in inadequate calorie intake or poor food choices. Without proper nutrition, patients risk muscle loss and metabolic decline. A structured meal plan supports long-term success and overall health.
  • Physical Activity Recommendations: Exercise enhances semaglutide's effectiveness. Encouraging strength training and daily activity reduces the likelihood of weight regain and promotes long-term fitness.
  • Hydration and Electrolyte Balance: Slower gastric emptying increases the risk of dehydration, which can lead to fatigue, dizziness, and other complications. Clinics should educate patients on proper hydration and strategies to maintain fluid balance throughout treatment.


Addressing Common Side Effects


The following strategies are the most effective to manage adverse reactions:


  • Nausea Management: Smaller meals, slower eating, and remaining upright after meals can help. Ginger supplements and electrolyte solutions provide additional relief.
  • Digestive Support: Constipation is common. Adequate fiber, hydration, and magnesium supplementation help regulate digestion. Clinics should provide clear recommendations.
  • Fatigue and Weakness: Nutrient-dense meals, proper protein intake, and sufficient rest improve energy levels. Stress management and quality sleep enhance overall well-being.


Addressing side effects early allows patients to stay engaged with their treatment plan. When clinics implement the above-mentioned strategies, they can help patients achieve better outcomes.


How To Get the Best Results from Semaglutide


Clinics that integrate supportive services position themselves as trusted partners in their patients' weight loss journeys. Offering a holistic treatment approach not only improves semaglutide success but also enhances patient retention and satisfaction. 


Body Shaping Treatments


Losing weight is a significant achievement, but many patients find their journey doesn't end when the scale reaches their goal. Excess skin, stubborn fat deposits, and changes in body composition can leave patients feeling frustrated despite their progress.


Non-invasive body shaping treatments provide a solution. When paired with semaglutide, these help patients achieve a sculpted, toned appearance.


Nutrient Optimization


Semaglutide helps control hunger, but reduced food intake can lead to lower energy levels, micronutrient deficiencies, or slowed metabolism. Supporting metabolic health ensures that patients maintain vitality and well-being throughout their weight loss journey.


Clinics that provide nutrient optimization not only improve semaglutide results but also reinforce long-term wellness.


Behavioral Coaching


Semaglutide helps regulate appetite, but patients still need guidance on building sustainable habits. Many struggle with emotional eating or inconsistent routines during their treatment. Without proper support, they may revert to old patterns once medication is reduced or discontinued.


Structured behavioral coaching helps patients develop a positive relationship with food. Clinics that integrate habit-building support increase the likelihood that patients maintain their progress and stay engaged in their weight loss journey.


Tracking Progress and Encouraging Accountability


Patients who feel supported and monitored are more likely to stay committed, which leads to better adherence.


Here's how clinical practices can effectively track semaglutide results:


  • Regular Check-Ins: Monthly or bi-weekly follow-ups to help adjust dosages, address concerns, and reinforce adherence.
  • Data-Driven Tracking: Body composition analysis provides better insights than scale weight alone. Encouraging measurable progress keeps patients motivated.
  • Community and Support Programs: Group coaching, online forums, or structured programs create accountability. Patients engaged in a support network maintain better results.


Complete the Transformation: Add Venus Body Shaping to Your Practice


Patients want more than weight loss — they want body transformation. Loose skin, stubborn fat, and lack of muscle tone often remain concerns even after losing pounds. 


If you're wondering how to get the best results from semaglutide, combining the medication with
body treatments enhances body-shaping results, supporting patients in achieving a more sculpted appearance. Venus' cutting-edge body contouring systems perfectly complement semaglutide, helping your clinic deliver comprehensive, results-driven care.


Venus Legacy™ enhances skin firming and cellulite reduction with Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields, giving patients firmer and smoother
skin without downtime.


Venus Bliss MAX™
combines diode laser fat reduction, EMS muscle toning, and radio frequency skin firming, delivering a complete, non-invasive body sculpting solution. These treatments seamlessly integrate with weight loss programs, keeping patients engaged and increasing retention.


Your patients want to look and feel their best. Give them the full-body transformation they're looking for while expanding your clinic's offerings and revenue potential. Invest in
Venus body contouring technology today and take your weight loss treatments to the next level.


Note: These are suggested best practices; patient recommendations should be tailored to each individual’s needs and health.


Contact Venus now to learn more and schedule a demo!



September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.